Ignite Creation Date:
2024-05-06 @ 12:42 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01642329
Status:
UNKNOWN
Last Update Posted:
2016-10-10
First Post:
2012-07-13
Brief Title:
Portuguese Registry on Acute Coronary Syndromes
Sponsor:
Portuguese Society of Cardiology
Organization:
Portuguese Society of Cardiology
Study Overview
Official Title:
Portuguese Registry on Acute Coronary Syndromes
Status:
UNKNOWN
Status Verified Date:
2016-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ProACS
Brief Summary:
The purpose of this Registry is creating a database management that allows continuous monitoring characteristics evolution prognostic indicators and management of patients with ACS admitted in Portuguese Hospitals and identify the appropriateness of clinical practice recommendations for diagnosis and treatment of ACS and monitor its evolution
Detailed Description:
Cardiovascular diseases remain the principal causes of death in Portugal and approximately one quarter of these are directly to ischemic heart disease especially Acute Coronary Syndromes ACS
In order to reduce mortality for ACS a significant number of new drugs and new techniques have been introduced into clinical practice resulting in important heterogeneity of approach and treatment of patients with ACS
The Portuguese Society of Cardiology have sought to review and incorporate in its recommendations the evidence to date with the aim to standardize diagnosis and treatment of patients with ACS which is not always able to in daily practice
Since it is essential to characterize the national reality of the ACS the Portuguese Society of Cardiology has promoted the Portuguese registry on Acute Coronary Syndromes aimed at bridging the knowledge gaps in this area of cardiovascular disease
This will include all adult patients 18 years diagnosed with Acute Coronary Syndrome ACS with 48 hours of evolution The inclusion is of responsibility of the last service of Cardiology where the patient was hospitalized The ACS is set to the presence of angina at rest last 48 hours with 1 ischemic electrocardiographic changes ST-segment deviations or negative T waves and or 2 elevation of biomarker cardiac troponin and CK-MB above the reference value For diagnosis ACS with ST elevation is considered to be persistently elevated 30 minutes of the ST segment The rest should be considered as ACS ST-segment elevation In the absence of angina the SCA will be considered consistent elevation curve ascending descending biomarker above reference value for cardiac troponin or higher 2 times the value of reference to the CK-MB associated with other clinical manifestations such as ill-defined chest discomfort or dyspnea
Are included patients participating in clinical trials
Are excluded patients with MI after revascularization procedures EAM type 4 and 5 and MI type 2 classification according to the redefinition of Myocardial Infarction 2007 the Joint ESC ACCF AHA WHF Task Force
In order to reduce mortality for ACS a significant number of new drugs and new techniques have been introduced into clinical practice resulting in important heterogeneity of approach and treatment of patients with ACS
The Portuguese Society of Cardiology have sought to review and incorporate in its recommendations the evidence to date with the aim to standardize diagnosis and treatment of patients with ACS which is not always able to in daily practice
Since it is essential to characterize the national reality of the ACS the Portuguese Society of Cardiology has promoted the Portuguese registry on Acute Coronary Syndromes aimed at bridging the knowledge gaps in this area of cardiovascular disease
This will include all adult patients 18 years diagnosed with Acute Coronary Syndrome ACS with 48 hours of evolution The inclusion is of responsibility of the last service of Cardiology where the patient was hospitalized The ACS is set to the presence of angina at rest last 48 hours with 1 ischemic electrocardiographic changes ST-segment deviations or negative T waves and or 2 elevation of biomarker cardiac troponin and CK-MB above the reference value For diagnosis ACS with ST elevation is considered to be persistently elevated 30 minutes of the ST segment The rest should be considered as ACS ST-segment elevation In the absence of angina the SCA will be considered consistent elevation curve ascending descending biomarker above reference value for cardiac troponin or higher 2 times the value of reference to the CK-MB associated with other clinical manifestations such as ill-defined chest discomfort or dyspnea
Are included patients participating in clinical trials
Are excluded patients with MI after revascularization procedures EAM type 4 and 5 and MI type 2 classification according to the redefinition of Myocardial Infarction 2007 the Joint ESC ACCF AHA WHF Task Force
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ProACS | REGISTRY | Portuguese Registry on Acute Coronary Syndromes | None |